Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
01/2011
01/20/2011WO2011007839A1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use
01/20/2011US20110015404 Electroluminescent Materials
01/20/2011US20110015214 Tricyclic benzo[4,5]thieno-[2,3-d]pyrimidine-4-yl-amin derivatives, their salts, process for producing the compounds and their pharmaceutical use
01/20/2011US20110015212 Pyrimidinones as pi3k inhibitors
01/20/2011CA2767887A1 Benzimidazole analogues for the treatment or prevention of flavivirus infections
01/20/2011CA2765661A1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use
01/19/2011EP2274310A1 Fused thiophenes and methods for making and using same
01/19/2011EP2274296A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
01/19/2011EP2064217B1 An improved process for the preparation of clopidogrel and its pharmaceutically acceptable salts
01/19/2011EP1067123B1 Nitrogenous heterocyclic compounds
01/19/2011CN101952259A Benzodiazepine compound and pharmaceutical composition
01/19/2011CN101948479A 普拉格雷中间体及其制备方法 Prasugrel intermediates and preparation method
01/19/2011CN101948474A Preparation method for crystal I-type clopidogrel bisulfate
01/19/2011CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same
01/19/2011CN101560213B Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application
01/18/2011US7872258 improved performance, have good mobility and the semiconducting layer is stable in air
01/18/2011US7872019 Polymorphs and amorphous form of (S)-(+)-clopidogrel bisulfate
01/18/2011US7872003 Anticancer agents; kinase inhibitor; immunotherapy; viricides; antiinflammatory agents
01/18/2011CA2432148C Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient
01/18/2011CA2432077C Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists
01/13/2011WO2011006066A1 Cb receptor agonists
01/13/2011WO2011005842A1 Anti-rsv compounds
01/13/2011WO2011004869A1 Substituted benzochalcogenoacene compound, thin film comprising the compound, and organic semiconductor device including the thin film
01/13/2011WO2011004392A1 Crystalline form of prasugrel hydrobromide, preparation and application thereof
01/13/2011WO2009156279A3 Process for the preparation of clopidogrel hydrogen sulfate crystalline form i
01/13/2011US20110009425 Tetrahydrothieno pyridines
01/13/2011US20110009415 Thienopyridazine Compounds, Their Preparations, Pharmaceutical Compositions And Uses
01/13/2011US20110009401 2-aza-bicyclo[2.2.1]heptane derivatives
01/13/2011US20110006287 Polymers with tunable band gaps for photonic and electronic applications
01/12/2011EP2001890B1 Tetrahydropyridothienopyrimidine compounds and use for the treatment of cell proliferative disorders
01/12/2011EP1398317B1 Alicyclic compound for optical material
01/12/2011CN101945917A Condensed polycyclic compound, condensed polycyclic polymer and organic thin film containing the compound or the polymer
01/12/2011CN101945878A Fused ring compound, method for producing the same, polymer, organic thin film containing the compound and/or the polymer, and organic thin film device and organic thin film transistor each comprising the organic thin film
01/12/2011CN101940214A Spiropiperidine derivatives for controlling pests
01/12/2011CN101426795B Process for preparing dorzolamide
01/12/2011CN101343278B Preparation method for hydrogenated pyridine derivant and its salt
01/12/2011CN101260112B Acethydrazide derivatives containing thieno[3.2-c]pyridine, preparation method and use thereof
01/12/2011CN101208347B Method of preparing clopidogrel and intermediates used therein
01/12/2011CN101029022B Process for the preparation of 4-phenoxy quinoline derivatives
01/11/2011US7868204 Inhibitors of histone deacetylase
01/11/2011US7868038 Compounds as cannabinoid receptor ligands
01/11/2011CA2538032C Thienopyrazoles
01/11/2011CA2430124C Lactam compounds and pharmaceutical use thereof
01/11/2011CA2422054C Bicyclic heteroaromatic compounds
01/11/2011CA2407593C Fused heteroaryl derivatives
01/06/2011US20110003966 Photochromic and eletrochromic compounds and methods of synthesizing and using same
01/06/2011US20110003846 Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate
01/06/2011US20110003806 Heteroaryls and uses thereof
01/06/2011US20110003788 Fused heterocyclic derivative and use thereof
01/05/2011EP2268618A1 Compounds and compositions as tlr activity modulators
01/05/2011EP2268281A1 Thienopyrroles and pyrrolothiazoles as new therapeutic agents
01/05/2011EP2094706B1 Substituted 2,5-dfflydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands
01/05/2011CN1988934B Tetrahydropyridothiophenes
01/05/2011CN101939325A Organic semiconductor material
01/05/2011CN101939296A Carbazole-containing materials in phosphorescent light emitting diodes
01/04/2011US7863442 Processes for the synthesis of olanzapine
01/04/2011CA2640591C Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances
01/04/2011CA2505555C Spirocyclic cyclohexane derivatives
01/04/2011CA2456901C Thieno[2,3-d]pyrimidines with combined lh and fsh agonistic activity
12/2010
12/30/2010US20100331550 Thienothiophene derivatives
12/30/2010US20100331348 Tropane derivatives useful as pesticides
12/30/2010US20100331329 Benzamide derivatives useful as histone deacetylase inhibitors
12/30/2010US20100331313 Thiazole Derivatives as Protein Kinase Inhibitors
12/30/2010US20100331283 Mitotic kinesin inhibitors and methods of use thereof
12/30/2010US20100327273 Dithienothiophene derivatives
12/29/2010WO2010151011A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
12/29/2010WO2010151006A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
12/29/2010WO2010149257A1 Alkoxy-thienopyrimidines as tgf-beta receptor kinase modulators
12/29/2010EP2266570A1 Use of binding partners for 5-HT5 receptors for treating neurodegenerative and neuropsychiatric disorders
12/29/2010EP2265626A2 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use
12/29/2010EP2265619A1 [1]benzothieno[3,2-b][1]benzothiophene compound and method for producing the same, and organic electronic device using the same
12/29/2010EP2265618A2 Aurora kinase inhibitors
12/29/2010EP2265270A1 2-aminopyridine kinase inhibitors
12/29/2010EP1560827B1 Anti-infective agents
12/29/2010EP1370530B1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/29/2010EP1292573B1 Substituted thioacetamides
12/29/2010CN101932586A Inhibitors of protein tyrosine kinase activity
12/29/2010CN101932575A Piperidine derivative
12/29/2010CN101429204B (3aS,4S,6aR)-4-(5'-oxo-hexyl)-tetrahydrochysene thiophene-[3,6-]imidazoline-2-ketone and synthesis thereof
12/29/2010CN101343280B Thiophene macrocyclic compound and preparation method for its derivant
12/29/2010CN101268081B 5,6-dimethylthieno(2,3-DI) pyrimidine derivatives, the preparation method thereof and the pharmaceutical composition comprising the same for anti-virus
12/29/2010CN101253179B Novel resinate complex of S-clopidogrel and production method thereof
12/29/2010CN101215291B Synthesis method of (+)-biotin and its derivatives
12/29/2010CA2766193A1 Alkoxy-thienopyrimidines as tgf-beta receptor kinase modulators
12/29/2010CA2765819A1 Heterocyclic compounds and their uses as inhibitors of p13 k activity
12/23/2010US20100324306 Electrochromic materials
12/23/2010US20100324038 Tetrahydropyridothiophenes for the treatment of proliferative diseases such as cancer
12/23/2010US20100324029 Therapeutic agents
12/23/2010US20100324017 Acylguanidine derivative
12/22/2010EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors
12/22/2010EP2264016A2 A process for producing pure form form of 2-Methyl-4-(4-Methyl-1-Piperazinyl)-10h-thieno[2,3-B][1,5] benzodiazepine
12/22/2010EP2262500A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
12/22/2010CN1988907B Dual small molecule inhibitors of cancer and angiogenesis
12/22/2010CN1802366B C-glycoside derivatives and salts thereof
12/21/2010US7855298 (1S,5R)-1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-3-azabicyclo[3.1.0]hexane; or(1S,5R)-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane; schizophrenia
12/21/2010US7855194 Pyrimidine, quinazoline, pteridine and triazine derivatives
12/21/2010CA2404594C Agent for prophylaxis and treatment of renal disease
12/16/2010WO2010052569A3 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
12/16/2010US20100317849 Process For Producing Pure And Stable Form Of 2-Methyl-4-(4-Methyl-1-Piperazinyl) -10H-Thieno[2,3-B] [1,5] Benzodiazepine
12/16/2010US20100317027 Sulfenic acid-reactive compounds and their methods of synthesis and use in detection or isolation of sulfenic acid-containing compounds
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 214